Synapse - Safety and efficacy of intraventricular (131)I-labeled monoclonal antibody 8H9 targeting the surface glycoprotein B7-H3 in patients with CNS/LM disease

Safety and efficacy of intraventricular (131)I-labeled monoclonal antibody 8H9 targeting the surface glycoprotein B7-H3 in patients with CNS/LM disease Meeting Abstract

Authors:	Kramer, K.; Kushner, B.; Modak, S.; Pandit-Taskar, N.; Tomlinson, U.; Donzelli, M.; Wolden, S.; Zanzonico, P.; Humm, J.; Haque, S.; Souweidane, M.; Greenfield, J.; Basu, E.; Roberts, S.; Carrasquillo, J.; Lewis, J.; Lyashchenko, S.; Larson, S.; Cheung, N. K.
Abstract Title:	Safety and efficacy of intraventricular (131)I-labeled monoclonal antibody 8H9 targeting the surface glycoprotein B7-H3 in patients with CNS/LM disease
Meeting Title:	The Society for Neuro-Oncology (SNO) and the Society for CNS Interstitial Delivery of Therapeutics (SCIDOT) Joint Conference on Therapeutic Delivery to the CNS
Journal Title:	Neuro-Oncology
Volume:	19
Issue:	Suppl. 6
Meeting Dates:	2017 Nov 15-16
Meeting Location:	San Francisco, CA
ISSN:	1522-8517
Publisher:	Oxford University Press
Date Published:	2017-11-01
Start Page:	vi272
Language:	English
ACCESSION:	WOS:000415152504078
PROVIDER:	Clarivate Analytics Web of Science
PROVIDER:	wos
DOI:	10.1093/neuonc/nox168.1119
PMCID:	PMC5692713
Notes:	Meeting Abstract: SCDT-38 -- Joint Conference of 22nd Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology / Conference of the Society-for-CNS-Interstitial-Delivery-of-the-Therapeutics (SCIDOT) on Therapeutic Delivery to the CNS -- NOV 15-19, 2017 -- San Francisco, CA -- Source: Wos